2022
DOI: 10.3390/pharmaceutics14040858
|View full text |Cite
|
Sign up to set email alerts
|

Dual Stimuli-Responsive Multifunctional Silicon Nanocarriers for Specifically Targeting Mitochondria in Human Cancer Cells

Abstract: Specific targeting, selective stimuli-responsiveness, and controlled release of anticancer agents are requested for high therapeutic efficiency with a minimal adverse effect. Herein, we report the sophisticated synthesis and functionalization of fluorescent mesoporous silicon (FMPSi) nanoparticles decorated with graphene oxide (GO) nanosheets. GO-wrapped FMPSi (FMPSi@GO) was loaded with a cisplatin (Cis) anticancer agent, and Cis-loaded FMPSi@GO (FMPSi-Cis@GO) exhibited the dual stimuli (pH and NIR)-responsive… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 82 publications
0
5
0
Order By: Relevance
“…Even if reaching the vicinity of the mitochondria, the extensively folded and compartmentalized inner mitochondrial membrane poses a hurdle for drug molecules attempting to gain entry. [ 126 ] Additionally, the mitochondrial membrane exhibits limited permeability, permitting only molecules smaller than 1500 Da and 5000 Da through the IMM and OMM respectively. [ 127 ] Small molecular drugs for mitochondrial dysfunction have widely been explored and applied to clinical therapy, and some approved drugs have been proposed as potentially therapeutic for mitochondria‐related diseases ( Table 2 ).…”
Section: Advantages Of Nanodrugs Targeting Mitochondrial Dysfunctionmentioning
confidence: 99%
“…Even if reaching the vicinity of the mitochondria, the extensively folded and compartmentalized inner mitochondrial membrane poses a hurdle for drug molecules attempting to gain entry. [ 126 ] Additionally, the mitochondrial membrane exhibits limited permeability, permitting only molecules smaller than 1500 Da and 5000 Da through the IMM and OMM respectively. [ 127 ] Small molecular drugs for mitochondrial dysfunction have widely been explored and applied to clinical therapy, and some approved drugs have been proposed as potentially therapeutic for mitochondria‐related diseases ( Table 2 ).…”
Section: Advantages Of Nanodrugs Targeting Mitochondrial Dysfunctionmentioning
confidence: 99%
“…In addition to adjuvants' ongoing use, NPs have emerged as promising adjuvant candidates because of their distinct qualities. Numerous common NPs [18], including lipids, gold [19], polymers [7], and silica [20][21], have been examined concerning their potential use as adjuvants in antiviral vaccines (Fig. 2).…”
Section: Adjuvants Vaccinementioning
confidence: 99%
“…Since the last decade of the 20th century, nanotechnology has been a field that is fast developing [5,[7][8]. To influence the performance of nanomaterials in biomedical applications, substantial advancements have been made in their nanoscale design and manipulation [9][10][11].…”
Section: ■ Introductionmentioning
confidence: 99%
“…Some classical and modern nanomaterials are applied in sensors and related fields, such as Silica NPs [ 4 , 5 ], Silicon NPs [ 6 ], MOF nanomaterials [ 7 , 8 , 9 ], and oxide metal NPs [ 10 , 11 ], although they still have certain limitations. Due to their interesting features and predictable fabrication processes, MXenes, a new two-dimensional (2D) material, were demonstrated to be promising in wearable sensory applications in 2011.…”
Section: Introductionmentioning
confidence: 99%